Novo Nordisk Sinks 6% on Strategy Day Jitters: Can a Rebranded Company Outrun a Shrinking Growth Story Shares plunged 6.1% to $40.58 as Novo Nordisk — now rebr

Novo Nordisk Sinks 6% on Strategy Day Jitters: Can a Rebranded Company Outrun a Shrinking Growth Story Shares plunged 6.1% to $40.58 as Novo Nordisk — now rebranding simply as "Novo" — opened its Capital Markets Day in London, with investors demanding answers about how the Danish drugmaker plans to…